Find your path to Tim
237 people in our graph share verified history with Tim — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedTim: together at Utrecht University (2005–2008)
×4Tim: together at IMD
×7Tim: together at Utrecht University
Chief Executive Officer at Agomab Therapeutics
Intro paths
→
In turn, Tim can intro founders to Agomab Therapeutics's investors below.
Agomab Therapeutics's investors · 8
AdBio partnersParisAndera PartnersParisAsabys PartnersMadrid · since 2022Canaan PartnersStamford · $500K – $20M checks · since 2023EQT Life SciencesLuxembourg · $11M – $66M checks · since 2023Fidelity InvestmentsBoston · since 2023Pontifax Venture CapitalHerzeliya · $6.3M – $128M checksV-Bio VenturesGhent · $270K – $2.2M checks
Experience
- AgomabCEOcurrent2019 — presentAntwerp, Belgium
- AM-PharmaVP Corporate Development2012 — 2020
- PRIMER ProfessionalsFounder2016 — 2018
- Aescap VentureSenior Associate2008 — 2012
- Mise en PlaceProject Leader2002 — 2006
Skills & more
LifesciencesTechnology TransferCommercializationPharmaceutical IndustryBiotechnologyVenture CapitalDue DiligenceBiopharmaceuticalsLicensingStart-upsR&DCorporate Development
+12 more
Drug DevelopmentPrivate EquityClinical DevelopmentBusiness DevelopmentMergers & AcquisitionsLife SciencesLeadershipcorporate developmentCommunicationTeamworkEmpathyEntrepreneurshipFrom Tim's professional profile.
Frequently asked questions
- Who is Tim Knotnerus?
- Chief Executive Officer at Agomab Therapeutics
- Where does Tim Knotnerus work?
- Tim Knotnerus is Chief Executive Officer at Agomab Therapeutics.
- Where did Tim Knotnerus go to school?
- Tim Knotnerus studied at IMD (Executive MBA); Utrecht University (MSc. Drug Innovation); Utrecht University (MSc. Science and Innovation Management).
Same school
Also attended IMD322
Karthik ChakkarapaniInvestor at Foundation CapitalKulpreet SinghOperating Advisor at OpenOceanMusaad AlkadiSr. Principal at Graphene VenturesGrant AllenFounding GP, Schneider Electric Ventures at Giant Ventures Global LlpFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgMichael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures Ag
+ 316 more
Also attended Utrecht University182
Bas JongtienLegal Counsel at DOB EquityMatthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at NoaberIrene KrijgsmanProgramma manager at NoaberMarlene van LooProgramma manager at NoaberRuben OsnabruggePartner & Chief Medical Officer at 415 Capital
+ 176 more
Shared employers
Also worked at Agomab4
Also worked at AM-Pharma5
Joël Jean-MairetManaging Partner at Ysios CapitalKlaus BreinerManaging Partner at Pureos BioventuresMarkwin VeldersAdvisory Committee member at Curie CapitalRobert FriesenFounder at AvidicureLars BoesgaardChief Financial Officer, Principal Financial Officer and Principal Accounting Officer at PDS Biotechnology Corp.
Also worked at Aescap Venture10
Patrick KrolPortfolio Manager at Aescap Life SciencesAlba MontoroAnalyst at Aescap Life SciencesHakan GokerManaging Director at M VenturesTristan MaguetSenior Associate Therapeutics Venture&Growth at Gilde HealthcareVictor BakkerHead of Investor Relations at Aescap Life SciencesLudovico DragoniAnalyst at Aescap Life Sciences
+ 4 more
